📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Mologen

1.1 - Company Overview

Mologen Logo

Mologen

Headquarter: Germany
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of biopharmaceutical research and clinical development of innovative drugs for cancer and infectious diseases.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Mologen

Hawaii Biotech Logo

Hawaii Biotech

HQ: United States Website
  • Description: Provider of biotechnology solutions focused on R&D of prophylactic vaccines for infectious diseases, including recombinant subunit vaccines (dengue, West Nile, Zika, tick-borne flaviviruses), viral hemorrhagic fevers (Crimean-Congo), and coronaviruses (SARS-CoV-2, pan-beta). Offers the GPI-0100 adjuvant, a protein production platform for vaccine development, and small molecule therapeutics for anthrax intoxication and botulism (BoNT type A).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Hawaii Biotech company profile →
Confluence Life Sciences Logo

Confluence Life Sciences

HQ: United States Website
  • Description: Provider of rational drug design-based discovery and development of mechanistically novel kinase inhibitors for human and animal health care, targeting key signal transduction enzymes involved in regulating cancer growth and survival and modulating chronic inflammation.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Confluence Life Sciences company profile →
Thallion Pharmaceuticals Logo

Thallion Pharmaceuticals

HQ: Canada Website
  • Description: Provider of biotechnology-based pharmaceutical development in infectious disease and oncology, currently emphasizing treatment for Shigatoxin-producing E. coli (STEC) bacterial infections; leading product candidate is Shigamabs®, a dual antibody.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Thallion Pharmaceuticals company profile →
ADC Therapeutics Logo

ADC Therapeutics

HQ: Switzerland Website
  • Description: Provider of targeted oncology therapies, developing antibody-drug conjugates and non-ADC products for hematological cancers and solid tumors using proprietary PBD-dimer technology. Offerings include ZYNLONTA (CD19 ADC), the LOTIS clinical trial program, ADCT-602 (CD22 ADC for acute lymphoblastic leukemia), Mipasetamab uzoptirine/ADCT-601 (AXL-targeting), PBD-dimer technology, and support for investigator-initiated trials.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ADC Therapeutics company profile →
Nascent Biotech Logo

Nascent Biotech

HQ: United States Website
  • Description: Provider of therapeutic antibodies and platform technologies. Pritumumab is a natural human IgG antibody targeting ecto-domain vimentin on adenocarcinomas, including brain cancers and melanoma; MultiPharm is a multi-agent (antibodies and/or cytokines) platform for potential treatment of cancer, diabetes, autoimmunity, and transplantation; and CLNH5 is a patented technology with four patents awarded by the United States Patent Office.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Nascent Biotech company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Mologen

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Mologen

2.2 - Growth funds investing in similar companies to Mologen

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Mologen

4.2 - Public trading comparable groups for Mologen

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Mologen

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Mologen

What does Mologen do?

Mologen is a provider of biopharmaceutical research and clinical development of innovative drugs for cancer and infectious diseases.

Who are Mologen's competitors?

Mologen's competitors and similar companies include Hawaii Biotech, Confluence Life Sciences, Thallion Pharmaceuticals, ADC Therapeutics, and Nascent Biotech.

Where is Mologen headquartered?

Mologen is headquartered in Germany.

How many employees does Mologen have?

Mologen has 1,000 employees 🔒.

When was Mologen founded?

Mologen was founded in 2010 🔒.

What sector and industry vertical is Mologen in?

Mologen is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Mologen

Who are the top strategic acquirers in Mologen's sector and industry

Top strategic M&A buyers and acquirers in Mologen's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Mologen?

Top strategic M&A buyers groups and sectors for Mologen include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Mologen's sector and industry vertical

Which are the top PE firms investing in Mologen's sector and industry vertical?

Top PE firms investing in Mologen's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Mologen's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Mologen's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Mologen's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Mologen include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Mologen's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Mologen?

The key public trading comparables and valuation benchmarks for Mologen include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Mologen for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Mologen with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Mologen's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Mologen with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Mologen's' sector and industry vertical?

Access recent funding rounds and capital raises in Mologen's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Mologen